Evaluation of 3-epi-25-hydroxyvitamin D3 cross-reactivity in the Roche Elecsys Vitamin D Total protein binding assay
| Autor: | Jos P.M. Wielders, Antonius M. Beijers, Henny van Daal, Johannes M.W. van den Ouweland, Marc G.L.M. Elisen, Gerard Steen |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Adult
Metabolite Clinical Biochemistry Endogeny Plasma protein binding Cross Reactions Mass spectrometry medicine.disease_cause Binding Competitive Cross-reactivity chemistry.chemical_compound Isomerism medicine Vitamin D and neurology Humans 3-epi-25-hydroxyvitamin D3 Calcifediol Immunoassay Chromatography Vitamin D-Binding Protein Ligand binding assay Biochemistry (medical) Infant Newborn General Medicine chemistry Blood Chemical Analysis Protein Binding |
| Zdroj: | Clinical Chemistry and Laboratory Medicine (CCLM). 52:373-380 |
| ISSN: | 1437-4331 1434-6621 |
| DOI: | 10.1515/cclm-2013-0702 |
| Popis: | Background: Presence of the 3-epi-25-hydroxyvitamin D3 [3-epi-25(OH)D3] metabolite affects accurate determination of 25(OH)D3 by most routine liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods and to an unknown extent in present immuno- and protein binding assays. We studied 3-epi-25(OH)D3 cross-reactivity in a competitive protein binding (CPB) assay (Roche Elecsys). Methods: Neonatal samples, containing up to 58% of 3-epi-25(OH)D3 were used for measurement by the CPB assay and by an LC-MS/MS method separating 25(OH)D3 and 3-epi-25(OH)D3. Analytical recovery was also studied by addition of exogenous 3-epi-25(OH)D3. Results: The CPB assay showed approximately 51% cross-reactivity to 3-epi-25(OH)D3 at exogenous addition. In contrast, there was minimal 3-epi-25(OH)D3 recognition by the CPB assay when present as the natural endogenous metabolite. Conclusions: The automated CPB assay displays minimal 3-epi-25(OH)D3 cross-reactivity in samples containing significant concentrations of endogenous 3-epi-25(OH)D3. Exogenous 3-epi-25(OH)D3 added to human serum or plasma seems to behave different from endogenous presence, and caution is warranted when using samples spiked with vitamin D metabolites for testing analytical specificity or external quality assurance in immuno- or protein binding assays. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|